Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rank in Stocks #40868
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Share Price
$0.02765
Last synced: 2024-12-23
Market Cap
$69.04K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Histogen Inc. (HSTO)

Category

Stock split history for Histogen Inc. (HSTO)
Histogen Inc. stock (symbol: HSTO) underwent a total of 2 stock splits.
The most recent stock split occurred on Jun 03, 2022.
One HSTO share bought prior to May 27, 2020 would equal to 0.005 HSTO shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2022-06-03 1:20 x0.05 x0.005
2020-05-27 1:10 x0.1 x0.1
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE